1 Overnight, 11 Follow Ups & 3 Calls

1 Overnight, 11 Follow Ups & 3 Calls

Study Number

8499-240

Group

2

Gender

both

Age

18 - 65

Location

Dallas, Texas

Compensation

$7,802

Study Dates

Jan. 16 - Apr. 11, 2023

Additional Information

The study drug is an investigational drug being developed for the potential treatment of autoimmune diseases (a condition in which the immune system mistakenly attacks the body). 

The purposes of this study are to evaluate how much of the study drug enters the circulation of the body when given as a new test solution formulation of the study drug compared to the original reference solution formulation of the study drug after subcutaneous (under the skin) injections using an auto-injector. The safety and tolerability of the test formulation of the study drug compared to the reference formulation of the study drug.

The study drug will be given as two separate injections using an auto-injector by inserting a needle just under the surface of your skin. You will be randomly assigned to a dose group to receive injections in both arms, both thighs, or both sides of the lower abdomen.



Labcorp Dallas, TX is recruiting for:

- Healthy Adults, age 18-65

- Body Mass Index between 18-34

- Study involves 1 stay of 1 night, plus 11 follow-up visits and 3 phone calls

- Compensation up to $7,802 may be provided for time and participation

- Up to $350 per qualified participant

Details

Call Now to Schedule Your Screening Appointment

Cohort 2:

Check-in: Jan 16
Check-out: Jan 17

Follow up Visits: Jan 19, 21, 24, 27, 31, Feb 7, 14, 28, Mar 14, 28, Apr, 11

Phone Calls: Feb 21, Mar, 7, 21

OR

Cohort 4:

Check-in: Jan 22
Check-out: Jan 23

Follow up Visits: Jan 25, 27, 30, Feb 2, 6, 13, 20, Mar 6,  20, Apr, 3

Phone Calls: Feb 27, Mar 13, 27,

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:

Your BMI: result